Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001214659-15-001939
Filing Date
2015-03-03
Accepted
2015-03-03 16:25:50
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014 s22615110k.htm 10-K 1545075
2 EXHIBIT 21.1 ex21_1.htm EX-21.1 5416
3 EXHIBIT 23.1 ex23_1.htm EX-23.1 3467
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 10071
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 10065
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 9365
  Complete submission text file 0001214659-15-001939.txt   8611643

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS dara-20141231.xml EX-101.INS 1131881
8 EXHIBIT 101.SCH dara-20141231.xsd EX-101.SCH 61615
9 EXHIBIT 101.CAL dara-20141231_cal.xml EX-101.CAL 65039
10 EXHIBIT 101.DEF dara-20141231_def.xml EX-101.DEF 171698
11 EXHIBIT 101.LAB dara-20141231_lab.xml EX-101.LAB 615918
12 EXHIBIT 101.PRE dara-20141231_pre.xml EX-101.PRE 398196
Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615 (816) 914-7027
DARA BioSciences, Inc. (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23776 | Film No.: 15669445
SIC: 2834 Pharmaceutical Preparations